Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.06% | $3.57B | €435.69B | 66.23% | 76 Outperform | |
| Roche Holding AG | 1.29% | $2.23B | CHF287.79B | 43.00% | 73 Outperform | |
| HSBC Holdings | 1.21% | $2.11B | £224.58B | 58.21% | 80 Outperform | |
| AstraZeneca | 1.16% | $2.00B | £213.91B | 24.00% | 80 Outperform | |
| Novartis AG | 1.15% | $1.99B | CHF225.91B | 20.41% | 80 Outperform | |
| Nestlé SA | 1.02% | $1.77B | CHF197.51B | 16.11% | 71 Outperform | |
| Toyota Motor | 0.91% | $1.57B | ¥48.55T | 28.76% | 80 Outperform | |
| Shell (UK) | 0.90% | $1.56B | £162.36B | 8.39% | 73 Outperform | |
| Siemens | 0.86% | $1.48B | €188.82B | 24.62% | 74 Outperform | |
| Mitsubishi UFJ Financial Group | 0.84% | $1.46B | ¥32.98T | 41.02% | 76 Outperform |